During the past decade, Bausch & Lomb Incorporated conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bausch & Lomb Incorporated" are "Cataract" (2 trials), "Inflammation" (2 trials), "Pain" (2 trials), "Bacterial Conjunctivitis" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Bausch & Lomb Incorporated" in a lesser frequency.

Most popular intervention types in "Bausch & Lomb Incorporated" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Loteprednol Etabonate Gel (BID)" (2 trials), "Besivance" (1 trials), "Gatifloxacin" (1 trials), "LE Gel" (1 trials) and "Latanoprostene bunod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bausch & Lomb Incorporated" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Bausch & Lomb Incorporated". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bausch & Lomb Incorporated, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bausch & Lomb Incorporated, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".